CloudCath closes $12M for catheter-based treatment monitoring platform
The company's initial product is designed for end stage renal disease patients receiving peritoneal dialysis in their homes. (Source: mobihealthnews)
Source: mobihealthnews - February 13, 2020 Category: Information Technology Source Type: news

Survival Similar for Hemodialysis, Peritoneal Dialysis
WEDNESDAY, Feb. 12, 2020 -- Peritoneal dialysis (PD) and in-center hemodialysis (HD) carry similar survival benefits, according to a review published online Jan. 28 in Nephrology Dialysis Transplantation. Mohamed E. Elsayed, M.B.B.S., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 12, 2020 Category: Pharmaceuticals Source Type: news

Peritoneal Dialysis Use Increases After Medicare Payment Reform Peritoneal Dialysis Use Increases After Medicare Payment Reform
Rates of home-based peritoneal dialysis for end-stage kidney disease are still relatively low in the US despite reported improvements in quality of life, other measures.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - November 28, 2019 Category: Transplant Surgery Tags: Nephrology News Source Type: news

Use of Peritoneal Dialysis Up Since Medicare Payment Reform
FRIDAY, Nov. 22, 2019 -- Following Medicare payment reform for dialysis, more patients started, stayed on, and switched to peritoneal dialysis (PD), according to a study published online Nov. 21 in the Clinical Journal of the American Society of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 22, 2019 Category: Pharmaceuticals Source Type: news

Expansion of Peritoneal Dialysis Feasible
TUESDAY, Sept. 10, 2019 -- Expansion of the use of peritoneal dialysis (PD) is feasible, according to a study published online Sept. 9 in JAMA Internal Medicine. Leonid V. Pravoverov, M.D., from The Permanente Medical Group in Oakland, California,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 10, 2019 Category: Pharmaceuticals Source Type: news

Fluid resuscitation with preventive peritoneal dialysis attenuates crush injury-related acute kidney injury and improves survival outcome - Zhou XL, Ni SZ, Xiong D, Cheng XQ, Xu P, Zhao Y.
This study was designed to investigate whether preventive peritoneal dialysis (PPD) is useful for renal pro... (Source: SafetyLit)
Source: SafetyLit - July 23, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Initial Volume Overload Tied to Death in Peritoneal Dialysis Initial Volume Overload Tied to Death in Peritoneal Dialysis
Largest study to date finds volume overload at start of peritoneal dialysis tied to increased death. Men and those with diabetes had higher levels of volume overload; dialysis practices vary around the world.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 14, 2019 Category: Consumer Health News Tags: Nephrology News Source Type: news

Volume Overload Present in Patients on Peritoneal Dialysis
THURSDAY, May 23, 2019 -- Volume overload is present before the start of peritoneal dialysis (PD), and is associated with risk of death, according to a study published online May 23 in the Clinical Journal of the American Society of Nephrology. Wim... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 23, 2019 Category: Pharmaceuticals Source Type: news

For-profit dialysis provider charges private insurers four times more than government payers
This study corroborates these findings in the dialysis market and could lead to policies that reduce the prices paid, in particular by private insurers.AUTHORSThe authors are Dr. Christopher Childers, Dr. Jill Dworsky and Dr. Melinda Maggard-Gibbons of the department of surgery, David Geffen School of Medicine at UCLA; and Gerald Kominski of the UCLA Center for Health Policy Research in the UCLA Fielding School of Public Health.JOURNALThestudy is published in JAMA Internal Medicine.FUNDINGThe Agency for Healthcare Research and Quality in the Department of Health and Human Services funded this study. (Source: UCLA Newsroom: Health Sciences)
Source: UCLA Newsroom: Health Sciences - May 14, 2019 Category: Universities & Medical Training Source Type: news

Meet the Chicago startup trying to build a better home dialysis machine
About 30 million people in the U.S. are estimated to have chronic kidney disease, according to the Centers for Disease Control and Prevention. However, with limited access to dialysis care, many patients go untreated. But a new Chicago startup aims to help. Simergent, founded in 2014 by Steve Lindo and Rick Pendergraft, is developing a home dialysis machine to deliver safe and effective automated peritoneal dialysis therapy to end stage renal disease patients. Though the product is still in the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 6, 2019 Category: American Health Authors: Katherine Davis Source Type: news

Peritoneal dialysis cost  saving versus haemodialysis
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 1, 2019 Category: Drugs & Pharmacology Source Type: news

Baxter acquires software developer True Process
Baxter (NYSE:BAX) said last week that it acquired healthcare software developer True Process. The company’s Vines software platform is designed for bedside data collection and normalization, according to a report from BizTimes. Founder Todd Dunsirn, who reportedly left the firm after the acquisition closed, told BizTimes that the company’s software aims to connect the various devices that monitor and collect patient-related data in a hospital. At one time, True Process had roughly 50 employees – half of whom worked remotely for client ICU Medical – and pulled in $10 million in revenue. Most of ...
Source: Mass Device - January 22, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Featured Hospital Care Mergers & Acquisitions Software / IT Wall Street Beat Baxter Source Type: news

Another Device Gets Added to the Peritoneal Dialysis Mix
AWAK Technologies has been granted a breakthrough device designation from FDA for a wearable and ultra-portable peritoneal dialysis (PD) device. The Singapore-based company’s AWAK PD device allows dialysis to be performed "on-the-go", overcoming the challenge of long hours of therapy and connection to large-size dialysis machines, currently faced by renal patients. The company said FDA’s designation was granted after reviewing the results from the First-In-Human safety trial of AWAK PD device, which was successfully completed in October 2018 at the Singapore General Hospital, S...
Source: MDDI - January 11, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Awak Technologies wins FDA breakthrough designation for portable PD device
Awak Technologies said today that it won a breakthrough device designation from the FDA for its wearable Awak Peritoneal Dialysis system. The Awak PD system is a portable, wearable peritoneal dialysis system which allows dialysis to be performed “on-the-go”, the Singapore-based company said. The breakthrough designation was granted based on results from the first-in-human safety trial of the Awak PD device, which completed last October. Data from the trial indicates that the system was able to efficiently remove the accumulation of toxins from the body with no serious adverse events experienced by patients usin...
Source: Mass Device - January 11, 2019 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Food & Drug Administration (FDA) Regulatory/Compliance Awak Technologies Pte. Source Type: news

USFDA grants breakthrough designation for AWAK ’s Peritoneal Dialysis device
Earlier this week, AWAK Technologies (AWAK), a Singapore-headquartered medical technology company focused on dialysis using regeneration technology for end-stage renal disease, announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to its AWAK Peritoneal Dialysis (AWAK PD) device, a wearable and ultra-portable PD system that incorporates AWAK ’s patented sorbent technology. (Source: mobihealthnews)
Source: mobihealthnews - January 11, 2019 Category: Information Technology Source Type: news

Baxter launches on-demand peritoneal dialysis solution device trial
Baxter (NYSE:BAX) said yesterday that it launched an FDA-cleared clinical trial of its on-demand peritoneal dialysis solution generation system intended to allow patients to make peritoneal dialysis solutions in small batches at home. The system is designed to use a small water filtration device, concentrates and Deerfield, Ill.-based Baxter’s Amia automated peritoneal dialysis system to turn a patient’s tap water into dialysis solution as needed for therapy sessions. Baxter said that it has enrolled the first patient in the trial, which looks to assess the efficacy and safety of the new system for pa...
Source: Mass Device - January 8, 2019 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Dialysis Baxter Source Type: news

Outcomes of Importance ID'd for Peritoneal Dialysis Patients
FRIDAY, Dec. 21, 2018 -- Patients undergoing peritoneal dialysis (PD) and their caregivers report that PD-related infection, mortality, and fatigue are outcomes of the highest importance, according to a study published online Dec. 20 in the Clinical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 21, 2018 Category: Pharmaceuticals Source Type: news

Peritoneal Dialysis Offers Flexibility in Austere Environments Peritoneal Dialysis Offers Flexibility in Austere Environments
Dr Desai highlights a number of unique aspects of peritoneal dialysis that make it attractive in difficult situations.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 26, 2018 Category: Consumer Health News Tags: Nephrology Viewpoint Source Type: news

What Causes Hyperkalemia?
Discussion Potassium (K+) is an alkali metal (Group 1 of periodic table with Hydrogen, Lithium and Sodium) with an anatomic number of 19. Its chemical symbol K, comes from the medieval Latin, kalium which means potash (mainly potassium carbonate or potassium hydroxide), the substance it was first isolated from. Potassium is an important cation and it mainly resides in the intracellular fluid with only a small amount in the extracellular fluid. Potassium regulates cell volume, pH and enzyme functions. Hyperkalemia is defined as a potassium level> 5.5 mEq/L in children and> 6.0 mEq/L in newborns. Hyperkalemia incre...
Source: PediatricEducation.org - September 24, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Do You Know How to Manage Japan ’s Revised Reimbursement Approach?
One significant change in Japan’s revised reimbursement process for new medical devices involves pricing. Applicants have been required for some time to provide pricing for their medical devices in other primary markets such as the United States, the United Kingdom, Germany, France, and Australia. Pricing has been based on list price, not market price, and the intention was to cap the reimbursement of medical devices. Given the typical differences between U.S. pricing and European pricing, the high U.S. price tended to pull the average up. (Please see the example below in Table 1; each price is converted ...
Source: MDDI - July 27, 2018 Category: Medical Devices Authors: Keisuke Suzuki Tags: Regulatory and Compliance Source Type: news

Baxter touts Theranova HDx dialysis tech study data
Baxter (NYSE:BAX) today released new data from studies exploring expanded hemodialysis with its Theranova dialyzer, touting the device’s ability to clear large middle molecules at a higher rate than standard hemodialysis and equal or faster removal rates compared to high-volume hemodiafiltration. Results from a number of studies and poster presentations on the Theranova dialyzer were presented at the 55th Congress of the European Renal Association and European Dialysis and Transplant Association meeting this month, Baxter said. The Deerfield, Ill.-based company’s Theranova dialyzer is designed to exte...
Source: Mass Device - May 31, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Clinical Trials Dialysis Baxter Source Type: news

Baxter updates Sharesource dialysis monitoring platform
Baxter (NYSE:BAX) today announced the launch of two updates for its Sharesource remote patient monitoring platform designed to monitor home peritoneal dialysis patients including the addition of a new modeling software tool and improvements to the clinical portal. The Deerfield, Ill.-based company announced the updates at the 55th Congress of the European Renal Association and European Dialysis and Transplant Association meeting this week. Baxter said that the first of its updates introduced the new Sharesource Adequest kinetic modeling software tool designed for direct integration into the platform to allow for impro...
Source: Mass Device - May 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blog Source Type: news

Readmissions High Among Peritoneal Dialysis Patients
(MedPage Today) -- Nearly a quarter readmitted within a month (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - April 12, 2018 Category: Urology & Nephrology Source Type: news

CVS is diving into the dialysis market
Drug store operator CVS Health (NYSE:CVS) said today it plans to expand into the dialysis market, launching a program focused on early identification of kidney disease and unveiling plans to develop a new home hemodialysis system. CVS said it will approach its entry into the dialysis market in stages, focusing on early disease identification and education, followed by the development of a home dialysis program for both hemodialysis and peritoneal dialysis. As part of its program, the company said it will launch a pivotal trial of a new home hemodialysis system in support of planned FDA submission, though it has not ye...
Source: Mass Device - April 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Research & Development CVS Health Source Type: news

Brooks Memorial to close dialysis unit, transition patients to new DaVita clinic
Three years after first proposing to close its dialysis service, Brooks Memorial Hospital is now moving forward with that plan just as a privately-owned national dialysis company prepares to open a clinic in Dunkirk. The hospital filed plans with the state Department of Health to discontinue outpatient dialysis services in the hospital and discontinue home peritoneal dialysis training and support. The program currently serves 33 patients. The decision also affects seven nurses who run the program.  The… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 6, 2017 Category: Health Management Authors: Tracey Drury Source Type: news

Adverse reaction with suvorexant for insomnia: acute worsening of depression with emergence of suicidal thoughts - Petrous J, Furmaga K.
A 59-year-old woman on daily peritoneal dialysis for end-stage renal failure received care at an outpatient psychiatric clinic for her diagnoses that include major depressive disorder, generalised anxiety disorder and insomnia disorder. Although there was ... (Source: SafetyLit)
Source: SafetyLit - October 30, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Initiating Peritoneal Dialysis After Catheter Insertion Initiating Peritoneal Dialysis After Catheter Insertion
Dr Desai discusses the uncertainty that remains about commencement of dialysis after catheter insertion.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 26, 2017 Category: Consumer Health News Tags: Nephrology Viewpoint Source Type: news

Kenya: Medics Urge State to Expand NHIF Cover for Kidney Treatment
[Nation] Medics want the National Hospital Insurance Fund (NHIF) cover to be expanded to cater for both peritoneal dialysis as well as post-transplant care of kidney patients. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 27, 2017 Category: African Health Source Type: news

7 medtech stories we missed this week: Sept. 15, 2017
[Image from unsplash.com]From Acera Surgical and Telos Medical’s partnership to Xtant Medical’s 510(k) clearance, here are seven medtech stories we missed this week but thought were still worth a mention. 1. Acera Surgical partners with Telos Medical for Restrata wound matrix trial Telos Partners announced in a Sept. 14 press release that Acera Surgical has chosen Telos to lead its Restrata wound matrix study. The study will surgery the clinical outcomes of Restrata treatments for diabetic foot ulcers and test for effectiveness and safety. Restrata is a fully synthetic wound matrix that is FDA-cleared for ...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Business/Financial News Clinical Trials Dental Diagnostics Food & Drug Administration (FDA) Regulatory/Compliance Surgical Acera Surgical Contego Medical Fresenius MedTech OBP Medical Pinnacle Sciences Plusoptix Telos Source Type: news

Baxter inks tech transfer deal for surgical devices out of Tel Aviv University
Baxter‘s (NYSE:BAX) said today it inked a licensing agreement with Tel Aviv University’s Ramot business engagement center through which the company aims to bring early stage research technologies in development at the university to the market. As part of the agreement, Baxter said it will gain an exclusive license for the TAU Technology Innovation Momentum Fund tech in 1 license agreement and TAU and Tel Aviv Sourasky Medical Center tech in a 2nd. “Baxter is committed to finding creative pathways to bring innovative solutions to the operating room. By working with leading experts at TAU and TASMC, we...
Source: Mass Device - July 6, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Research & Development Baxter Source Type: news

Local amplifiers of IL-4R{alpha}-mediated macrophage activation promote repair in lung and liver
The type 2 immune response controls helminth infection and maintains tissue homeostasis but can lead to allergy and fibrosis if not adequately regulated. We have discovered local tissue-specific amplifiers of type 2–mediated macrophage activation. In the lung, surfactant protein A (SP-A) enhanced interleukin-4 (IL-4)–dependent macrophage proliferation and activation, accelerating parasite clearance and reducing pulmonary injury after infection with a lung-migrating helminth. In the peritoneal cavity and liver, C1q enhancement of type 2 macrophage activation was required for liver repair after bacterial infectio...
Source: ScienceNOW - June 8, 2017 Category: Science Authors: Minutti, C. M., Jackson-Jones, L. H., Garcia-Fojeda, B., Knipper, J. A., Sutherland, T. E., Logan, N., Rinqvist, E., Guillamat-Prats, R., Ferenbach, D. A., Artigas, A., Stamme, C., Chroneos, Z. C., Zaiss, D. M., Casals, C., Allen, J. E. Tags: Immunology reports Source Type: news

Baxter touts Sharesource in-home peritoneal dialysis patient monitoring study data
Baxter (NYSE:BAX) today released data from multiple studies of its Sharesource remote patient monitoring technology used for peritoneal dialysis patient care. Data from the study was presented at the 54th Congress of the European Renal Association and European Dialysis and Transplant Association meeting this week. Sharesource is a 2-way cloud-based technology offered with the company’s Homechoice Claria automated PD system to allow providers to connect with patients using the device and verify patient adherence, the company said. Data from the 1st study study, which included 399 APD patients using remote patient...
Source: Mass Device - June 6, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Clinical Trials Patient Monitoring Baxter Source Type: news

Baxter inks R & D deal with Mayo Clinic, initial focus on kidney disease
Baxter (NYSE:BAX) said today that it inked a research & development collaborative deal with the Mayo Clinic to develop new technologies and therapies designed to improve patient therapeutic care. The pair will initially focus on kidney disease, with additional projects planned in other areas where breakthrough treatment options can be introduced and innovation can improve access to high-quality care. “We are excited about combining Mayo’s clinical and research expertise with Baxter’s ability to apply and scale innovation. We are confident that this collaboration will help accelerate discoveries, ...
Source: Mass Device - May 31, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Research & Development Baxter Source Type: news

DaVita buys Delafield dialysis clinic operator
DaVita Kidney Care said Monday that it has purchased a Delafield operator of dialysis clinics less than one week after reporting a tough quarter and two other acquisitions. DaVita Kidney Care, a division of Denver-based DaVita Inc. (NYSE: DVA), acquired Purity Dialysis, which has 10 centers in the Milwaukee area. Purity Dialysis clinics also provide outpatient hemodialysis and in-home peritoneal dialysis training. Terms of the deal were not disclosed. DaVita operat es about a dozen clinics in Milwaukee… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 9, 2017 Category: Pharmaceuticals Authors: Caitlin Hendee Source Type: news

DaVita scoops up Wisconsin operator of dialysis clinics
DaVita Kidney Care announced Monday that it has scooped up a Wisconsin operator of 10 dialysis clinics less than one week after reporting a tough quarter and two other acquisitions. DaVita Kidney Care, a division of Denver-based DaVita Inc. (NYSE: DVA), acquired Purity Dialysis, which has 10 centeres in the greater Milwaukee area. Purity Dialysis clinics also provide out-patient hemodialysis and in-home peritoneal dialysis training. Terms of the deal were not disclosed. "We look forward to providing… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 8, 2017 Category: American Health Authors: Caitlin Hendee Source Type: news

Baxter looks to combination device pathway for home peritoneal dialysis machine
Baxter (NYSE:BAX) said today that after communicating with the FDA, it will pursue a regulatory pathway as a combination product for its new home peritoneal dialysis solution system. The system is desigend to produce sterile PD solutions using a small water filtration device designed to be placed in a patient’s home and integrated into its AMIA automated peritoneal dialsysis system, the Deerfield, Ill.-based company said. “The FDA’s guidance is a pivotal milestone in advancing our new system forward for use by renal patients in an expedient manner. These technology advancements have the potential to ...
Source: Mass Device - May 3, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Food & Drug Administration (FDA) Regulatory/Compliance Baxter Source Type: news

Peritoneal Dialysis Safe for Post-Op Fluid Overload in Infants with CHD
(MedPage Today) -- Diuretics linked to higher risk of prolonged ventilation (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - February 21, 2017 Category: Surgery Source Type: news

Myths in Peritoneal Dialysis Myths in Peritoneal Dialysis
Common misperceptions about peritoneal dialysis may influence the practices of this therapy. Find out what they are.Current Opinion in Nephrology and Hypertension (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 4, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

New method makes peritoneal dialysis more tolerable
The addition of a new type of fluid for use in peritoneal dialysis makes it easier to tolerate and protects the cells in the abdominal cavity. This could make the peritoneum more resilient to harmful effects, report investigators. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 22, 2016 Category: Science Source Type: news

Baxter touts data on home peritoneal dialysis
Baxter (NYSE:BAX) today released data on its Sharesource remote patient monitoring and home-use Amia automated peritonial dialysis systems, touting its ability to improve early detection of adverse issue issues and faster treatment. Data on the platforms was presented at the American Society of Nephrology’s annual Kidney Week meeting last week in Chicago. Data from a case study of Baxter’s Sharesource indicated that the system was able to identify a displaced catheter through an early alert and diagnosis, which was surgically repositioned, the company said. A simulation study of 12 APD patient profiles ind...
Source: Mass Device - November 21, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Clinical Trials Patient Monitoring Baxter Source Type: news

Extraneal (Icodextrin Peritoneal Dialysis Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 31, 2016 Category: Drugs & Pharmacology Source Type: news

Dianeal PD-2 (Peritoneal Dialysis Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 2, 2016 Category: Drugs & Pharmacology Source Type: news

Dianeal Low Calcium (Low Calcium Peritoneal Dialysis Solutions) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 2, 2016 Category: Drugs & Pharmacology Source Type: news

Dianeal PD-1 (Peritoneal Dialysis Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 2, 2016 Category: Drugs & Pharmacology Source Type: news

Baxter, Satellite Healthcare ink dialysis deal
Baxter (NYSE:BAX) and Satellite Healthcare said today that they inked a deal to bring Baxter’s dialysis products into Satellite’s 80-site renal care network. Satellite, a non-profit group, is the 6th-largest dialysis and kidney disease treatment provider in the U.S. The 4-year deal will see Satellite deploy Baxter’s Amia automated peritoneal dialysis system and Revaclear dialyzer for high-flux hemodialysis. Baxter won 510(k) clearance from the FDA in October 2015 for the Amia system. The financial details of the agreement were not disclosed. “Baxter and Satellite Healthcare ...
Source: Mass Device - August 25, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Dialysis Wall Street Beat Baxter International Satellite Healthcare Source Type: news

Two classes of medications linked to similar results in peritoneal dialysis patients
A new study examined two classes of medications commonly prescribed to prevent cardiovascular events in dialysis patients and found no significant difference in outcomes. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 8, 2016 Category: Science Source Type: news

NxStage Medical Details New Features, Hints at Peritoneal Dialysis System
(Source: MDDI)
Source: MDDI - August 8, 2016 Category: Medical Equipment Authors: mthibault Tags: Development Medical Device Business Source Type: news

Two classes of medications linked to similar results in peritoneal dialysis patients
(LA BioMed) A new study examined two classes of medications commonly prescribed to prevent cardiovascular events in dialysis patients and found no significant difference in outcomes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 8, 2016 Category: Global & Universal Source Type: news

Baxter touts study indicating cost savings with Revaclear dialyzer
This study suggests that clinicians may be able to reduce patient exposure to ESAs without sacrificing hemoglobin levels,” study author Dr. Maggie Gellens said in a press release. Decreasing ESA use by an average dose of 275 units would mean potential savings of $4.39 per hemodialysis session, according to the report, which comes out to $660 savings per patient per year at 3 dialysis sessions a week. ”Reducing the cost of one hemodialysis session can be significant considering that more than 60 million hemodialysis sessions are delivered in the U.S. annually,” Baxter global HEOR senior director Suzanne La...
Source: Mass Device - July 27, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Clinical Trials Baxter International Source Type: news

MassDevice.com +5 | The top 5 medtech stories for June 29, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. ‘Donnie Brasco’ brother sues Zimmer A former sales rep for Zimmer Biomet – who is the brother of the FBI agent on whom the movie “Donnie Brasco” is based – yesterday filed a $15 million lawsu...
Source: Mass Device - June 29, 2016 Category: Medical Equipment Authors: Melissa Annand Tags: News Well Plus 5 Source Type: news